Orthopediatrics (KIDS) Invested Capital (2015 - 2026)

Orthopediatrics has reported Invested Capital for 12 years, with the latest figure at $445.4 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 4.91% year-over-year to $445.4 million; the trailing twelve-month figure through Mar 2026 stood at $445.4 million (up 4.91% YoY), and the FY2025 full-year result was $452.6 million, up 4.76% from the prior year.
• Invested Capital for Q1 2026 stood at $445.4 million, down from $452.6 million in the prior quarter.
• The five-year high for Invested Capital was $458.2 million in Q2 2025, with the low at $216.1 million in Q1 2022.
• Average Invested Capital over 5 years is $390.4 million, with a median of $384.3 million recorded in 2022.
• Year-over-year, Invested Capital retreated 3.24% in 2022 and soared 73.12% in 2023.
• Tracing KIDS's Invested Capital over 5 years: stood at $379.6 million in 2022, then climbed by 2.25% to $388.1 million in 2023, then gained by 11.33% to $432.0 million in 2024, then climbed by 4.76% to $452.6 million in 2025, then retreated by 1.6% to $445.4 million in 2026.
• The last three Invested Capital figures came in at $445.4 million (Q1 2026), $452.6 million (Q4 2025), and $454.6 million (Q3 2025), per Business Quant data.

Peer Comparison